Navigation Links
Hyperion Therapeutics Completes Phase 2 Data Analysis and Schedules End of Phase 2 Meeting With FDA for HPN-100 in the Chronic Treatment of Urea Cycle Disorders
Date:11/12/2008

SOUTH SAN FRANCISCO, Calif., Nov. 12 /PRNewswire/ -- Hyperion Therapeutics, Inc. today reported completion of data analysis for its Phase 2 clinical trial designed to evaluate the safety, tolerability and ammonia scavenging effects of HPN-100 versus BUPHENYL(R) (sodium phenylbutyrate), the current standard of care in patients with urea cycle disorders. Data from the trial will be presented at an upcoming medical conference.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070905/AQW076LOGO)

"We are encouraged by this trial and the potential to develop a new therapy for patients with urea cycle disorders," said Dr. Bruce Scharschmidt, Senior Vice President and Chief Medical Officer of Hyperion Therapeutics, Inc. "Based on the results, we plan to meet with the Food and Drug Administration in early 2009 to discuss our Phase 3 development program."

"We are pleased with the progress of the HPN-100 clinical program," said Cindy LeMons, Executive Director of the National Urea Cycle Disorders Foundation (NUCDF). "The urea cycle disorder community encourages the development of treatment alternatives."

Hyperion and Ucyclyd Pharma, Inc., a subsidiary of Medicis Pharmaceutical Corporation, entered into a collaboration agreement for HPN-100 in August 2007. Under the terms of the agreement, Hyperion is conducting ongoing research and development of HPN-100 for urea cycle disorders, hepatic encephalopathy, and other forms of hyperammonemia.

About Urea Cycle Disorder

Urea cycle disorders are inherited, inborn errors of metabolism present in an estimated 1 in 10,000 births in the United States. Patients with urea cycle disorders are deficient in one of the key enzymes that comprise the urea cycle, the body's primary vehicle for removing ammonia, a potent neurotoxin, from the bloodstream. Onset may occur at any age depending on the severity of the disorder.
'/>"/>

SOURCE Hyperion Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Hyperion Therapeutics Elects Lota Zoth to Board of Directors
2. Hyperion Therapeutics Announces Enrollment of First Patient in Phase 2 Clinical Trial in Patients With Hepatic Encephalopathy
3. Transition Therapeutics Announces First Quarter Fiscal 2009 Financial Results
4. Duska Therapeutics and DSM Pharmaceuticals in Manufacturing Collaboration for PSVT Drug Product
5. Transition Therapeutics to Hold Conference Call on First Quarter Fiscal 2009 Financial Results on Monday, November 10th, at 4:30 P.M. EST
6. Nektar Therapeutics Repurchases $100 Million of Convertible Debt and Reports Third Quarter 2008 Financial Results
7. Cell Therapeutics, Inc. (CTI) Rodman & Renshaw Healthcare Conference Presentation to be Webcast
8. Cornerstone Therapeutics Announces New Board of Directors
9. Orexigen(R) Therapeutics Announces Webcast of Third Quarter Financial Results on November 6, 2008
10. Cornerstone BioPharma Announces Completion of Merger with Critical Therapeutics
11. Cell Therapeutics, Inc. (CTI) Oppenheimer & Co. Healthcare Conference Presentation to be Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2013)... May 25, 2013 Radius Engineering ... shelter company in the US and has been ... for over 35 years. M.E. and President, Walton ... of NBC Weapon Fundamentals and Shelter Engineering Standards, ... bible on shelter engineering. McCarthy is considered the ...
(Date:5/25/2013)... Center, FL (PRWEB) May 25, 2013 Absolute ... one of many of the NALA’s businesses throughout the country ... Amshel chose to participate in the nationwide event as he ... a Lieutenant Colonel in the Army. He said, “I wanted ... the community I serve, but I live here too.” , ...
(Date:5/25/2013)... (PRWEB) May 25, 2013 The ... ranging from irritable bowel syndrome (IBS) to bloating, ... among the most long-lasting, embarrassing, frustrating and difficult ... foods for digestive health have provided a ... are many factors contributing to digestive health issues, ...
(Date:5/25/2013)... 25, 2013 According to a ... Market, 2013–2018", published by MarketsandMarkets is expected to ... of 5.54% which analyzes and studies the major ... Europe, Asia, and Rest of the World. , ... Tables , 87 Figures , ...
(Date:5/25/2013)... According to world-renowned scholars, Queen Cleopatra VII was ... ever lived. Cleopatra’s legendary beauty moved nations and her ... men in her time. Cleopatra was also a scientist ... glowing and fresh, from her legendary milk baths to ... cyprus grass. , Cleopatra was said to possess the ...
Breaking Medicine News(10 mins):Health News:Radius Engineering International Inc. Offers Tools to Stay Safe and Recover From Any Disaster 2Health News:Radius Engineering International Inc. Offers Tools to Stay Safe and Recover From Any Disaster 3Health News:Dr. Craig Amshel of Absolute Surgical Specialists Offering Bowel Prep During the Shop Local for a Cause Event 2Health News:Natural Foods For Digestive Health Report and Video Published by BetterDigestion.org 2Health News:Homeland Security Market to Reach $544.02 Billion by 2018 at a CARC of 5.54% - New Report by MarketsandMarkets 2Health News:Homeland Security Market to Reach $544.02 Billion by 2018 at a CARC of 5.54% - New Report by MarketsandMarkets 3Health News:Homeland Security Market to Reach $544.02 Billion by 2018 at a CARC of 5.54% - New Report by MarketsandMarkets 4Health News:The Cleopatra Lift - A New Non Surgical Option to Aging Offered by Vancouver Physician 2Health News:The Cleopatra Lift - A New Non Surgical Option to Aging Offered by Vancouver Physician 3
... ,the time has come, for health care reformWASHINGTON, March ... Board member Senator Bob Dole introduced fellow Kansan and ... Governor Sebelius, nominee for Secretary of Health and ... and Pensions Committee. Video from the hearing is ...
... N.Y., March 31 By doing a set of vigorous ... patients who had gone partially blind as a result of ... to scientists who published their results in the April 1 ... retraining is not common for people who suffer blindness after ...
... immigrant community continue to make news headlines, one project is trying to ... Shidad: Stories of Somali Health, based in Minneapolis, is a DVD produced ... in the US and abroad. , ... Madison, WI (PRWEB) March 31, ...
... March 31 /PRNewswire-FirstCall/ - Bradmer Pharmaceuticals Inc. ("Bradmer" ... and fiscal year operational and financial results.Operational HighlightsDuring ... achieved the following steps for its multi-center Phase ... treatment for glioblastoma multiforme (GBM), the most advanced ...
... 31 Insmed Inc. (Nasdaq: INSM ), a ... sale of all of the Company,s assets related to its ... Inc. As a result of this closing, Insmed has ... assets. After fees, taxes and other costs related to ...
... CHICAGO, March 31 The latest "Mad About Options" ... (STJ).(Logo: http://www.newscom.com/cgi-bin/prnh/20090323/AQM046LOGO )"Mad About Options" co-hosts, ... and Chief Investment Strategist Jud Pyle, outline option strategies ... disagree with the "Mad Money" host,s picks. This video ...
Cached Medicine News:Health News:Bipartisan Policy Center Founder Bob Dole Introduces Governor Sebelius at Confirmation Hearing to Be Next HHS Secretary 2Health News:Rigorous Visual Training Teaches the Brain to See Again After Stroke 2Health News:Rigorous Visual Training Teaches the Brain to See Again After Stroke 3Health News:Rigorous Visual Training Teaches the Brain to See Again After Stroke 4Health News:Rigorous Visual Training Teaches the Brain to See Again After Stroke 5Health News:New Routes' Immigrant Project 'Egal Shidad' Aims to Solve Somali Mental Health Problems through New Media 2Health News:New Routes' Immigrant Project 'Egal Shidad' Aims to Solve Somali Mental Health Problems through New Media 3Health News:New Routes' Immigrant Project 'Egal Shidad' Aims to Solve Somali Mental Health Problems through New Media 4Health News:Bradmer announces 2008 fourth quarter and fiscal year operational and financial results 2Health News:Bradmer announces 2008 fourth quarter and fiscal year operational and financial results 3Health News:Bradmer announces 2008 fourth quarter and fiscal year operational and financial results 4Health News:Bradmer announces 2008 fourth quarter and fiscal year operational and financial results 5Health News:Bradmer announces 2008 fourth quarter and fiscal year operational and financial results 6Health News:Bradmer announces 2008 fourth quarter and fiscal year operational and financial results 7Health News:Bradmer announces 2008 fourth quarter and fiscal year operational and financial results 8Health News:Bradmer announces 2008 fourth quarter and fiscal year operational and financial results 9Health News:Insmed Completes Sale of Follow-On Biologics Platform to Merck & Co., Inc. for Gross Proceeds of $130 Million 2Health News:Insmed Completes Sale of Follow-On Biologics Platform to Merck & Co., Inc. for Gross Proceeds of $130 Million 3
(Date:5/24/2013)... , May 24, 2013 China Biologic Products, ... leading fully integrated plasma-based biopharmaceutical company in ... recently learned from a public announcement issued by Shanghai ... company listed on Shenzhen Stock Exchange, that on May ... ("Ms. Chan"), one of the shareholders of the ...
(Date:5/24/2013)... , May 24, 2013 ... administration for systemic delivery of therapeutic agents has been ... inhalation drug delivery showing significant promise. The crucial formulation ... a delivery device play a major role in the ... made in the development of new formulation techniques and ...
(Date:5/23/2013)... SAN DIEGO y PARÍS, 24 de ... VOLC ), un destacado desarrollador y fabricante ... para mejorar la diagnosis y tratamiento de la ... resultados preliminares del ensayo ADVISE ( Ad enosine ... tenosis E valuation) II durante la sesión ...
Breaking Medicine Technology:China Biologic Comments on the Proposed Shanghai RAAS Transaction 2China Biologic Comments on the Proposed Shanghai RAAS Transaction 3China Biologic Comments on the Proposed Shanghai RAAS Transaction 4Inhalaltion Drug Delivery: 11-12 September - Berlin, Germany 2Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 2Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 3Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 4Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 5Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 6
... Board: CONX ), a worldwide developer and marketer ... 10-K and reported financial results. The report disclosed that the ... June 30, 2010. Some of the results highlighted by the ... year was $815,981 vs. $403,741 for the prior year. ...
... Inc. (Nasdaq: BMRN ) announced today the appointment ... Board of Directors. "We are extremely pleased to ... Directors.  With experience, vision and proven strength in leadership and ... important role in the company," said Pierre Lapalme, Chairman of ...
Cached Medicine Technology:Corgenix Reports Fiscal 2010 Financial Results 2Corgenix Reports Fiscal 2010 Financial Results 3BioMarin Appoints William Young and Kenneth Bate to Its Board of Directors 2BioMarin Appoints William Young and Kenneth Bate to Its Board of Directors 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: